Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106219173 | 10621917 | 3 | F | 2009 | 20160713 | 20141203 | 20160830 | PER | US-JNJFOC-20141109655 | JANSSEN | 0.00 | T | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106219173 | 10621917 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | UNKNOWN | 0 | TABLETS | ||||||||
| 106219173 | 10621917 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | IN VARYING DOSES OF 0.5 - 3 MG | U | UNKNOWN | 0 | TABLETS | |||||||
| 106219173 | 10621917 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | UNKNOWN | 0 | TABLETS | ||||||||
| 106219173 | 10621917 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | IN VARYING DOSES OF 0.5 - 3 MG | U | UNKNOWN | 0 | TABLETS | |||||||
| 106219173 | 10621917 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | UNKNOWN | 0 | TABLETS | ||||||||
| 106219173 | 10621917 | 6 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | IN VARYING DOSES OF 0.5 - 3 MG | U | UNKNOWN | 20272 | TABLETS | |||||||
| 106219173 | 10621917 | 7 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 106219173 | 10621917 | 8 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 106219173 | 10621917 | 9 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 20272 | TABLETS | ||||||||
| 106219173 | 10621917 | 10 | SS | INVEGA | PALIPERIDONE | 1 | Oral | AT BEDTIME | U | U | 21999 | 6 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | |||||
| 106219173 | 10621917 | 11 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
| 106219173 | 10621917 | 12 | C | HALDOL | HALOPERIDOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106219173 | 10621917 | 1 | Hallucination, auditory |
| 106219173 | 10621917 | 2 | Hallucination, auditory |
| 106219173 | 10621917 | 3 | Schizophrenia |
| 106219173 | 10621917 | 4 | Schizophrenia |
| 106219173 | 10621917 | 5 | Bipolar disorder |
| 106219173 | 10621917 | 6 | Bipolar disorder |
| 106219173 | 10621917 | 7 | Hallucination, auditory |
| 106219173 | 10621917 | 8 | Schizophrenia |
| 106219173 | 10621917 | 9 | Bipolar disorder |
| 106219173 | 10621917 | 10 | Product used for unknown indication |
| 106219173 | 10621917 | 11 | Product used for unknown indication |
| 106219173 | 10621917 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106219173 | 10621917 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106219173 | 10621917 | Abnormal weight gain | |
| 106219173 | 10621917 | Drug ineffective | |
| 106219173 | 10621917 | Galactorrhoea | |
| 106219173 | 10621917 | Gynaecomastia | |
| 106219173 | 10621917 | Hyperprolactinaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106219173 | 10621917 | 1 | 2008 | 0 | ||
| 106219173 | 10621917 | 2 | 2008 | 0 | ||
| 106219173 | 10621917 | 3 | 2008 | 0 | ||
| 106219173 | 10621917 | 4 | 2008 | 0 | ||
| 106219173 | 10621917 | 5 | 2008 | 0 | ||
| 106219173 | 10621917 | 6 | 2008 | 0 |